Skip to main content
. 2018 Jul 19;219(2):254–263. doi: 10.1093/infdis/jiy442

Figure 3.

Figure 3.

Percent of participants with human immunodeficiency virus (HIV) RNA ≤400 copies/mL over follow-up, by treatment group for START, SMART, and the pooled deferred/intermittent and immediate/continuous ART groups. Graph is truncated at 48 months. Abbreviations: ART, antiretroviral therapy; DC, drug conservation; DEF, deferred ART; IMM, immediate ART; SMART, Strategies for Management of Antiretroviral Therapy; START, Strategic Timing of Antiretroviral Treatment; VS, viral suppression.